PBM vs. NIVF, CERO, SRNE, KTTA, XWEL, AQB, HEPA, INBS, PULM, and IMCC
Should you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include NewGenIvf Group (NIVF), CERo Therapeutics (CERO), Sorrento Therapeutics (SRNE), Pasithea Therapeutics (KTTA), XWELL (XWEL), AquaBounty Technologies (AQB), Hepion Pharmaceuticals (HEPA), Intelligent Bio Solutions (INBS), Pulmatrix (PULM), and IM Cannabis (IMCC). These companies are all part of the "medical" sector.
NewGenIvf Group (NASDAQ:NIVF) and Psyence Biomedical (NASDAQ:PBM) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, analyst recommendations, media sentiment, earnings, institutional ownership, valuation, profitability, risk and dividends.
NewGenIvf Group has a beta of 0.48, meaning that its stock price is 52% less volatile than the S&P 500. Comparatively, Psyence Biomedical has a beta of -0.11, meaning that its stock price is 111% less volatile than the S&P 500.
66.2% of NewGenIvf Group shares are held by institutional investors. Comparatively, 77.4% of Psyence Biomedical shares are held by institutional investors. 31.8% of NewGenIvf Group shares are held by insiders. Comparatively, 3.6% of Psyence Biomedical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
In the previous week, Psyence Biomedical's average media sentiment score of 0.00 equaled NewGenIvf Group'saverage media sentiment score.
NewGenIvf Group and Psyence Biomedical both received 0 outperform votes by MarketBeat users.
Summary
NewGenIvf Group beats Psyence Biomedical on 2 of the 3 factors compared between the two stocks.
Get Psyence Biomedical News Delivered to You Automatically
Sign up to receive the latest news and ratings for PBM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PBM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Psyence Biomedical Competitors List
Related Companies and Tools
